Actieve functies van Elmar Schärli
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Xigen SA
 Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Financieel Directeur/CFO | - | - |
Zilentin AG
 Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Directeur/Bestuurslid | - | - |
Loopbaan van Elmar Schärli
Eerdere bekende functies van Elmar Schärli
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Financieel Directeur/CFO | 01-11-2019 | 01-11-2021 |
Statistieken
Internationaal
| Zwitserland | 3 |
| Bermuda | 2 |
Operationeel
| Director of Finance/CFO | 2 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Health Technology |
Zilentin AG
Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Health Technology |
- Beurs
- Insiders
- Elmar Schärli
- Ervaring
